Research map: Novel VSV-G Variants with Enhanced Blinding for Targeted Delivery of Lentiviral Vectors

Back to the article

Papers in this map

  1. UCSF ChimeraX : Tools for structure building and analysis · Elaine C. Meng · 2023 · 4770 citations · Cited by this paper
  2. Retroviral Transduction of Human CD4 + T Cells with Membrane-Attached IL-10 Generates Type 1-Like Regulatory T Cells · 2026 · Related
  3. Viral vector platforms within the gene therapy landscape · Jote Bulcha · 2021 · 1394 citations · Cited by this paper
  4. Optimization of Alpha-1 Antitrypsin Expression from Adeno-Associated Virus Vectors · 2026 · Related
  5. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients · Steven J. Howe · 2008 · 1300 citations · Cited by this paper
  6. Prenatal Intraportal Delivery of Polymeric Nanoparticles to Fetal Rhesus Monkeys ( Macaca mulatta ) · 2026 · Related
  7. LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus · Danit Finkelshtein · 2013 · 674 citations · Cited by this paper
  8. High Prevalence of Preexisting Neutralizing Antibodies Against Adeno-Associated Virus Capsids in Mongolian People with Hemophilia · 2026 · Related
  9. Simultaneous Optimization of Biomolecular Energy Functions on Features from Small Molecules and Macromolecules · Hahnbeom Park · 2016 · 656 citations · Cited by this paper
  10. Quantification of Lentiviral Vectors with Nucleic Acid Dyes · 2026 · Related
  11. Crystal Structure of the Low-pH Form of the Vesicular Stomatitis Virus Glycoprotein G · Stéphane Roche · 2006 · 442 citations · Cited by this paper
  12. CAR-T Cell Therapy: Manufacturing Platforms and Clinical Consequences · 2026 · Related
  13. A Cochlear Cell Line as an in vitro System for Drug Ototoxicity Screening · Gilda M. Kalinec · 2003 · 320 citations · Cited by this paper
  14. A Review of the Challenge of Pre-Existing Humoral Immunity in Adeno-Associated Virus Gene Therapy and Potential Solutions · 2026 · Related
  15. Gene therapy on the move · Kerstin B. Kaufmann · 2013 · 275 citations · Cited by this paper
  16. Capsid Engineering of Adeno-Associated Viruses for Targeted Gene Therapy in Kidney Diseases · 2026 · Related
  17. In vivo human T cell engineering with enveloped delivery vehicles · Jennifer R. Hamilton · 2024 · 266 citations · Cited by this paper
  18. Ethical and Regulatory Considerations for Developing Gene Therapies Involving Genome Editing · 2026 · Related
  19. Structural basis for the recognition of LDL-receptor family members by VSV glycoprotein · Jovan Nikolić · 2018 · 253 citations · Cited by this paper
  20. Helper-Dependent Adenoviral Vectors: Recent Advances and Emerging Applications · 2026 · Related
  21. VSV-G Pseudotyped Lentiviral Vector Particles Produced in Human Cells Are Inactivated by Human Serum · Nicholas J. DePolo · 2000 · 222 citations · Cited by this paper
  22. Targeted Cell Entry of Lentiviral Vectors · Sabrina Funke · 2008 · 220 citations · Cited by this paper
  23. The Soluble Serum Protein Gas6 Bridges Virion Envelope Phosphatidylserine to the TAM Receptor Tyrosine Kinase Axl to Mediate Viral Entry · Kouki Morizono · 2011 · 211 citations · Cited by this paper
  24. Gulping rather than sipping: macropinocytosis as a way of virus entry · Jason Mercer · 2012 · 210 citations · Cited by this paper
  25. Mystery solved: VSV-G-LVs do not allow efficient gene transfer into unstimulated T cells, B cells, and HSCs because they lack the LDL receptor · Fouzia Amirache · 2014 · 203 citations · Cited by this paper
  26. Selectively Receptor-Blind Measles Viruses: Identification of Residues Necessary for SLAM- or CD46-Induced Fusion and Their Localization on a New Hemagglutinin Structural Model · Sompong Vongpunsawad · 2003 · 188 citations · Cited by this paper
  27. Hematologic Cancer after Gene Therapy for Cerebral Adrenoleukodystrophy · Christine Duncan · 2024 · 142 citations · Cited by this paper
  28. Surface-Engineered Viral Vectors for Selective and Cell Type-Specific Gene Delivery · Christian J. Buchholz · 2015 · 137 citations · Cited by this paper
  29. Prediction of Protein Mutational Free Energy: Benchmark and Sampling Improvements Increase Classification Accuracy · Brandon Frenz · 2020 · 134 citations · Cited by this paper
  30. In vivo CAR engineering for immunotherapy · Yan-Ruide Li · 2025 · 132 citations · Cited by this paper
  31. Antigen identification and high-throughput interaction mapping by reprogramming viral entry · Connor S. Dobson · 2022 · 131 citations · Cited by this paper
  32. Antibody-targeted cell fusion · Takafumi Nakamura · 2004 · 120 citations · Cited by this paper
  33. In-vivo B-cell maturation antigen CAR T-cell therapy for relapsed or refractory multiple myeloma · Jia Li Xu · 2025 · 114 citations · Cited by this paper
  34. Receptor-Targeted Nipah Virus Glycoproteins Improve Cell-Type Selective Gene Delivery and Reveal a Preference for Membrane-Proximal Cell Attachment · Ruben R. Bender · 2016 · 110 citations · Cited by this paper
  35. Cell type-specific delivery by modular envelope design · Daniel Strebinger · 2023 · 99 citations · Cited by this paper
  36. Macropinocytosis drives T cell growth by sustaining the activation of mTORC1 · John C. Charpentier · 2020 · 83 citations · Cited by this paper
  37. Engineered cell entry links receptor biology with single-cell genomics · Bingfei Yu · 2022 · 78 citations · Cited by this paper
  38. Targeted in vivo delivery of genetic medicines utilizing an engineered lentiviral vector platform results in CAR T and NK cell generation · James I. Andorko · 2025 · 76 citations · Cited by this paper
  39. Molecular Architecture of the Bipartite Fusion Loops of Vesicular Stomatitis Virus Glycoprotein G, a Class III Viral Fusion Protein · Xiangjie Sun · 2007 · 67 citations · Cited by this paper

Source: OpenAlex (CC0)